Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Coleman, Craig I ^a,b   Sidovar, Matthew F ^c   Roberts, Matthew S ^b   Kohn, Christine ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

^c ACORDA THERAPEUTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAREGIVER; COHORT ANALYSIS; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; GAIT DISORDER; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; QUALITY OF LIFE; RETIREMENT; UNITED STATES; WALKING AID;

ADULT; COSTS AND COST ANALYSIS; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY OF LIFE; REGISTRIES; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84872789586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054756     Document Type: Article

References (18)

1. Frohman EM, (2003) Multiple sclerosis. Med Clin North Am 87: 867-897.
2. Patwardhan MB, Matchar DB, Samsa GP, McCrory DC, Williams RG, et al. (2005) Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler 11: 232-239.
3. Nortvedt MW, Riise T, Myhr KM, Nyland HI, (1999) Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 53: 1098-1103.
4. Naci H, Fleurence R, Birt J, Duhig A, (2010) Economic burden of multiple sclerosis: a systematic review of the literature. Pharmacoeconomics 28: 363-379.
5. Kobelt G, Berg J, Atherly D, Hadjimichael O, (2006) Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology 66: 1696-1702.
6. Costs and Quality of Life in Multiple Sclerosis - A Cross-Sectional Observational Study in the UK (with Gisela Kobelt, Peter Lindgren, David Parkin, David Francis, Michael Johnson and David Bates, SSE/EFI Working Paper No 398, August 2000 (2000) Available: http://www.google.com/url?sa=t&rct=j&q=kobelt%20working%20paper&source=web&cd=2&ved=0CC8QFjAB&url=http%3A%2F%2Fswopec.hhs.se%2Fhastef%2Fpapers%2Fhastef0594.pdf&ei=R5XqTtywC6jj0QGR4aTFCQ&usg=AFQjCNG0KH5oQ8kv4jJJliWejUfWjT2M9A&cad=rja.Accessed 2012 Aug 17.
7. Bethoux F, Bennett S, (2011) Evaluating walking in patients with multiple sclerosis. Int J MS Care 13: 4-14.
8. Consortium of Multiple Sclerosis Centers. CMSC-NARCOMS: Information. Available: http://www.mscare.org/cmsc/CMSC-NARCOMS-Information.html. Accessed 2011 Aug 9.
9. Hohol MJ, Orav EJ, Weiner HL, (1999) Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 5: 349-354.
10. Marrie RA, Goldman M, (2007) Validity of performance scales for disability assessment in multiple sclerosis. Mult Scler 13: 1176-1182.
11. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ, (2003) Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 60: 31-36.
12. Bureau of Labor Statistics. Employer costs for employee compensation - March 2011. Available: http://www.bls.gov/news.release/archives/ecec_06082011.pdf. Accessed 2012 Aug 17.
13. The EuroQol Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16: 199-208.
14. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ, (2005) Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 43: 1078-1086.
15. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, et al. (2005) A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 76: 58-63.
16. Salter AR, Cutter GR, Tyry T, Marrie RA, Vollmer T, (2010) Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin 26: 493-500.
17. Cohen JT, (2010) Walking speed and economic outcomes for walking-impaired patients with multiple sclerosis. Expert Rev Pharmacoecon Outcomes Res 10: 595-603.
18. Kobelt G, Berg J, Lindgren P, Fredrikson S, Jonsson B, (2006) Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 77: 918-926.